Author pages are created from data sourced from our academic publisher partnerships and public sources.
Share This Author
The prevention of progression of arterial disease and diabetes (POPADAD) trial: factorial randomised placebo controlled trial of aspirin and antioxidants in patients with diabetes and asymptomatic…
Objective To determine whether aspirin and antioxidant therapy, combined or alone, are more effective than placebo in reducing the development of cardiovascular events in patients with diabetes… Expand
Low grade chronic inflammation in women with polycystic ovarian syndrome.
- C. Kelly, H. Lyall, J. Petrie, G. Gould, J. Connell, N. Sattar
- The Journal of clinical endocrinology and…
- 1 June 2001
Low grade chronic inflammation as reflected by increased C-reactive protein (CRP) concentrations independently predicts those at risk for coronary heart disease (CHD) and type 2 diabetes. Women with… Expand
Direct Activation of AMP-activated Protein Kinase Stimulates Nitric-oxide Synthesis in Human Aortic Endothelial Cells*
- Valerie A Morrow, F. Foufelle, J. Connell, J. Petrie, G. Gould, I. Salt
- Chemistry, Medicine
- Journal of Biological Chemistry
- 22 August 2003
Recent studies have indicated that endothelial nitric-oxide synthase (eNOS) is regulated by reversible phosphorylation in intact endothelial cells. AMP-activated protein kinase (AMPK) has previously… Expand
Risk of Cardiovascular Disease and Total Mortality in Adults with Type 1 Diabetes: Scottish Registry Linkage Study
Helen Colhoun and colleagues report findings from a Scottish registry linkage study regarding contemporary risks for cardiovascular events and all-cause mortality among individuals diagnosed with… Expand
Estimated life expectancy in a Scottish cohort with type 1 diabetes, 2008-2010.
IMPORTANCE Type 1 diabetes has historically been associated with a significant reduction in life expectancy. Major advances in treatment of type 1 diabetes have occurred in the past 3 decades.… Expand
Diabetes, left ventricular systolic dysfunction, and chronic heart failure.
Chronic heart failure (HF) and diabetes mellitus (DM) commonly coexist. Each condition increases the likelihood of developing the other, and when they occur together in the same patient the risk of… Expand
Cardiovascular and metabolic effects of metformin in patients with type 1 diabetes (REMOVAL): a double-blind, randomised, placebo-controlled trial.
- J. Petrie, N. Chaturvedi, +13 authors H. Colhoun
- The lancet. Diabetes & endocrinology
- 1 August 2017
BACKGROUND Metformin might reduce insulin requirement and improve glycaemia in patients with type 1 diabetes, but whether it has cardiovascular benefits is unknown. We aimed to investigate whether… Expand
Effects of prior moderate exercise on postprandial metabolism and vascular function in lean and centrally obese men.
- J. Gill, Ali Al-Mamari, +5 authors M. Caslake
- Journal of the American College of Cardiology
- 1 March 2005
OBJECTIVES We investigated whether a session of prior exercise could ameliorate postprandial endothelial dysfunction. BACKGROUND Endothelial function is impaired after fat ingestion, and this may… Expand
Diabetes, Hypertension, and Cardiovascular Disease: Clinical Insights and Vascular Mechanisms
Hypertension and type 2 diabetes are common comorbidities. Hypertension is twice as frequent in patients with diabetes compared with those who do not have diabetes. Moreover, patients with… Expand
Detailed Physiologic Characterization Reveals Diverse Mechanisms for Novel Genetic Loci Regulating Glucose and Insulin Metabolism in Humans
OBJECTIVE Recent genome-wide association studies have revealed loci associated with glucose and insulin-related traits. We aimed to characterize 19 such loci using detailed measures of insulin… Expand